Dual GIP/GLP 1 receptor agonist
Tirzepatide
40 mg
40 mg / 3 ml prefilled pen for subcutaneous use.
- Presentation
- 40 mg/3 ml (13.3 mg/ml) prefilled pen
- Pharmaceutical form
- Solution for injection
- Route of administration
- Subcutaneous
- Storage
- 2 to 8 °C. Do not freeze. Protect from light.
For clinical, packaging or regulatory enquiries, contact our medical information team.
Make an enquiryProduct information
Overview
The 40 mg presentation of Tirzepatide delivers a higher concentration of 13.3 mg/ml across the same 3 ml pen platform, supporting extended titration schedules within a single device.
Presentation details
- High concentration formulation
- Shared pen platform across strengths
- For subcutaneous use only
Specification
- Active ingredient
- Tirzepatide
- Class
- Dual GIP/GLP 1 receptor agonist
- Concentration
- 13.3 mg/ml
- Fill volume
- 3 ml
- Device
- Multi-dose prefilled pen
- Pack
- 1 pen per carton
